Three years after the publication of the German (S3) evidence based Psoriasis guidelines: Was it worth the effort?;Drei Jahre Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris - Hat der Aufwand sich gelohnt?

JDDG - Journal of the German Society of Dermatology

Volumn 7, Issue 12, 2009, Pages 1044-1047

  Nast, Alexander ^a   Rzany, Berthold ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Care; Evaluation; Guidelines; Psoriasis; Treatment

Indexed keywords

ALGORITHM; HEALTH CARE QUALITY; HUMAN; POPULATION; PRACTICE GUIDELINE; PSORIASIS; REVIEW; TOTAL QUALITY MANAGEMENT;

GERMANY; GUIDELINE ADHERENCE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PSORIASIS; QUALITY ASSURANCE, HEALTH CARE;

EID: 71149085142     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2009.07275.x     Document Type: Review

References (17)

1. Arbeitsgemeinschaft der Wissenschaftli-chen Medizinischen Fachgesellschaften und Ärztliche Zentralstelle für Qualitäts-sicherung. AWMF Guidelines Manual. Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2001 95.
2. Follmann M, Sterry W, Rzany B. Development of the evidence-based guidelines for psoriasis - a project of the German Dermatological Society (DDG). J Dtsch Dermatol Ges 2005 3 : 678 689.
3. Nast A, Kopp IB, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mro-wietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B. S3-Leitlinie zur Behand-lung der Psoriasis vulgaris. J Dtsch Dermatol Ges 2006 4 Suppl 2 : S1 126.
4. Nast A, Kopp I, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mro-wietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B. German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version). Arch Dermatol Res 2007 299 : 111 138. (Pubitemid 46835379)
5. Nast A, Kopp IB, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mro-wietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B. [S3-Guidelines for the therapy of psoriasis vulgaris]. J Dtsch Dermatol Ges 2007 5 Suppl 3 : S1 119.
6. Nast A, Erdmann R, Pathirana D, Rzany B. Translating psoriasis treatment guidelines into clinical practice -the need for educational interventions and strategies for broad dissemination. J Eval Clin Pract 2008 14 : 803 806.
7. Nast A, Reytan N, Rosumeck S, Rzany B. Kosten und Aufwand bei der Erstellung einer S3-Leitlinie. J Dtsch Dermatol Ges 2007 5 : 198.
8. Nast A, Reytan N, Rosumeck S, Erdmann R, Rzany B. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry. J Eur Acad Dermatol Venereol 2008 22 : 1337 1342.
9. Nast A, Erdmann R, Hofelich V, Reytan N, Orawa H, Sterry W, Rzany B. Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German psoriasis guidelines. Arch Dermatol Res 2009 301 : 553 559.
10. Radtke MA, Reich K, Blome C, Kopp I, Rustenbach SJ, Schafer I, Augustin M. Evaluation of Quality of Care and Guideline-Compliant Treatment in Psoriasis. Development of a New System of Quality Indicators. Dermatology 2009 219 (1 54 8.
11. Weisenseel P, Kuznetsov AV, Prinz JC. [Implementation of the S3-guidelines for systemic and UV therapy of moderate to severe psoriasis vulgaris by an algorithm]. J Dtsch Dermatol Ges 2007 5 : 683 688.
12. Reich K, Mrowietz U. Treatment goals in psoriasis. J Dtsch Dermatol Ges 2007 5 : 566 574.
13. Augustin M. [PsoNet - more health care quality through regional psoriasis networks]. J Dtsch Dermatol Ges 2008 6 : 263 264.
14. CBO. Richtlijn foto(chemo)therapie en systemische therapie bij ernstige chronische plaque psoriasis. Van Zuiden Communications 2003.
15. Nast A, Spuls P, Ormerod A, Reytan N, Saiag P, Smith C, Rzany B. A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: "AGREE-ing" on a common base for European evidence-based psoriasis treatment guidelines. J Eur Acad Dermatol Venereol 2009 23 (7 782 787.
16. Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A, Griffiths C, Hönigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B. European S3-Guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009 23 (s2) 1 69.
17. Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler D, Finlay AY, Griffiths CE, Jackson K, McHugh NJ, McKenna KE, Reynolds NJ, Ormerod AD. British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol 2005 153 : 486 497.